Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer

Shixiu Wu(Fujian Medical University), Gang Li(Hong Kong Polytechnic University), Congying Xie(Wenzhou Medical University), Lvhua Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ruifei Xie(Hangzhou Cancer Hospital), Jin Hu(Wuhan University of Technology), Xuebang Zhang(Wenzhou Medical University), Duojie Li(First Affiliated Hospital of Bengbu Medical College), Wenfeng Li(Qingdao University), Hongyan Zhang(Third People's Hospital of Hangzhou), Hui Liu(Yantaishan Hospital), Jianhua Wang(Xuzhou Medical College), Ming Chen(First Affiliated Hospital Zhejiang University), Hongbo Zhang(Åbo Akademi University), Bing Xia(Rutgers, The State University of New Jersey), Jing Zhao(Hangzhou Cancer Hospital), Hao Jiang(Unknown), Conghua Xie(Wuhan University), Zhifeng Tian(Lishui Central Hospital), Kewei Huang(Jiangsu Cancer Hospital), Honglei Luo(Huaian First People’s Hospital), Wei Hu(University of Manchester), Ni Zhang(Tongji Hospital), Ping Zhang(Wenzhou Medical University), Lin Du(University of California, Los Angeles), Anping Zheng(Anyang Tumor Hospital), Fujun Zhao(Anyang Tumor Hospital), Xilong Lian(Kaohsiung Medical University), Xiuhua Bian(Jiangsu Cancer Hospital), Dexi Du(Lishui Central Hospital), Bangxian Tan(Affiliated Hospital of North Sichuan Medical College)
European Journal of Cancer
March 20, 2018
Cited by 28


Related Papers